A small feasibility study suggests that the HER-2 antibody combined with "dose-dense" chemotherapy is associated with acceptable rates of heart failure. Heartwire
Review the interrelated role of cardiometabolic risk factors, including obesity, dyslipidemia, and diabetes, in the global pandemic of cardiovascular disease.
In patients treated with statins, non-high-density lipoprotein cholesterol and apolipoprotein B levels were closely linked with cardiovascular outcome vs low-density lipoprotein cholesterol levels. Medscape Medical News
